Ibuprofen lysine
Alternative Names: Ibuprofen lysinate - Recordati Rare Diseases; NeoProfen; PedeaLatest Information Update: 30 Oct 2021
At a glance
- Originator Farmacon-IL
- Developer Nycomed Russia; Orphan Europe; Recordati Rare Diseases
- Class Antirheumatics; Basic amino acids; Nonsteroidal anti-inflammatories; Phenylpropionates
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Patent ductus arteriosus
Most Recent Events
- 30 Apr 2015 Launched for Patent ductus arteriosus (In neonates) in Greece (IV)
- 03 Feb 2015 Launched for Patent ductus arteriosus (In neonates) in Austria (IV)
- 11 Nov 2014 Launched for Patent ductus arteriosus (In neonates) in Portugal (IV)